ORCHPHARMAPharmaceuticals
Orchid Pharma Ltd — Cash Flow Statement
₹482.45
-5.52%
Orchid Pharma Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -130.89 Cr | 61.18 Cr | -66.58 Cr | 78.07 Cr | — |
| Issuance Of Capital Stock | 0.00 | 391.94 Cr | 0.00 | 0.00 | — |
| Capital Expenditure | -150.11 Cr | -64.81 Cr | -84.91 Cr | -14.40 Cr | — |
| End Cash Position | 21.11 Cr | 3.60 Cr | 22.60 Cr | 4.31 Cr | — |
| Beginning Cash Position | 3.60 Cr | 22.60 Cr | 4.31 Cr | 15.69 Cr | — |
| Changes In Cash | 17.51 Cr | -19.00 Cr | 18.29 Cr | -11.39 Cr | — |
| Financing Cash Flow | 25.22 Cr | 167.04 Cr | 31.17 Cr | -216.80 Cr | — |
| Interest Paid Cff | -3.11 Cr | -4.90 Cr | -32.23 Cr | -32.01 Cr | — |
| Net Common Stock Issuance | 0.00 | 391.94 Cr | 0.00 | 0.00 | — |
| Common Stock Issuance | 0.00 | 391.94 Cr | 0.00 | 0.00 | — |
| Net Issuance Payments Of Debt | 28.34 Cr | -220.01 Cr | 63.39 Cr | -184.79 Cr | — |
| Net Short Term Debt Issuance | 28.56 Cr | 0.00 | 173.20 Cr | 20.00 Cr | — |
| Net Long Term Debt Issuance | -0.22 Cr | -220.01 Cr | 63.39 Cr | -184.79 Cr | — |
| Investing Cash Flow | -26.93 Cr | -312.03 Cr | -31.21 Cr | 112.94 Cr | — |
| Interest Received Cfi | 18.74 Cr | 12.00 Cr | 0.46 Cr | 0.49 Cr | — |
| Net Investment Purchase And Sale | 104.44 Cr | -259.22 Cr | -5.31 Cr | 12.84 Cr | — |
| Net PPE Purchase And Sale | -150.11 Cr | -64.81 Cr | -26.37 Cr | 145.10 Cr | — |
| Purchase Of PPE | -150.11 Cr | -64.81 Cr | -84.91 Cr | -14.40 Cr | — |
| Operating Cash Flow | 19.22 Cr | 125.99 Cr | 18.34 Cr | 92.47 Cr | — |
| Taxes Refund Paid | -0.94 Cr | 0.63 Cr | -0.30 Cr | -1.91 Cr | — |
| Change In Working Capital | -108.53 Cr | -7.84 Cr | -79.06 Cr | 59.57 Cr | — |
| Change In Other Current Assets | 6.22 Cr | -39.58 Cr | 10.57 Cr | 26.08 Cr | — |
| Change In Payable | -6.78 Cr | 54.85 Cr | 13.91 Cr | 47.36 Cr | — |
| Change In Inventory | -62.15 Cr | -35.49 Cr | -56.08 Cr | 2.54 Cr | — |
| Change In Receivables | -49.07 Cr | 19.65 Cr | -41.65 Cr | -22.92 Cr | — |
| Other Non Cash Items | -2.74 Cr | 64000.00 | 31.61 Cr | 31.59 Cr | — |
| Provisionand Write Offof Assets | -6.97 Cr | -0.27 Cr | 1.19 Cr | 3.67 Cr | — |
| Depreciation And Amortization | 34.55 Cr | 33.24 Cr | 54.79 Cr | 87.02 Cr | — |
| Depreciation | 34.55 Cr | 33.24 Cr | 54.78 Cr | 86.99 Cr | — |
| Net Foreign Currency Exchange Gain Loss | -5.85 Cr | 7.63 Cr | 1.64 Cr | 0.14 Cr | — |
| Gain Loss On Sale Of PPE | 0.32 Cr | 0.19 Cr | -39.98 Cr | -4000.00 | — |
| Net Income From Continuing Operations | 99.46 Cr | 89.05 Cr | 46.32 Cr | -1.95 Cr | — |
| Repayment Of Debt | — | -208.55 Cr | -109.81 Cr | -204.79 Cr | -125.08 Cr |
| Issuance Of Debt | — | 0.00 | 173.20 Cr | 20.00 Cr | 0.00 |
| Long Term Debt Payments | — | -208.55 Cr | -109.81 Cr | -204.79 Cr | -125.08 Cr |
| Long Term Debt Issuance | — | 0.00 | 173.20 Cr | 20.00 Cr | 0.00 |
| Net Business Purchase And Sale | — | 0.00 | 0.00 | -45.50 Cr | 0.00 |
| Purchase Of Business | — | 0.00 | 0.00 | -45.50 Cr | 0.00 |
| Sale Of PPE | — | 0.00 | 58.55 Cr | 159.51 Cr | 0.29 Cr |
| Amortization Cash Flow | — | 1.13 Cr | 78000.00 | 0.03 Cr | — |
| Short Term Debt Issuance | — | — | 173.20 Cr | 20.00 Cr | — |
| Purchase Of Investment | — | — | -5.31 Cr | — | — |
| Sale Of Business | — | — | 57.61 Cr | 159.41 Cr | — |
| Gain Loss On Investment Securities | — | — | -0.02 Cr | -89.18 Cr | -1.94 Cr |
| Sale Of Investment | — | — | — | 12.84 Cr | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Orchid Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.